Becton Dickinson (XSWX:BDX) Tax Provision: CHF-187 Mil (TTM As of Mar. 2026)


XSWX:BDX Becton Dickinson & Co XSWX:BDX
77 GF Score
Price CHF122.44
GF Value CHF153.22
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Tax Provision?

Becton Dickinson XSWX:BDX +0.53% 77 Tax Provision is CHF-187 Mil as of Mar. 2026. GuruFocus rates XSWX:BDX with a GF Score™ of 77/100 and a GF Value™ of CHF153.22. The stock has 3 warning signs investors should review.

Becton Dickinson's tax provision for the three months ended in Mar. 2026 was CHF-60 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-187 Mil.

Becton Dickinson Tax Provision Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Tax Provision Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -81.21 -144.05 -118.75 -254.16 -161.61

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.00 -104.90 -13.53 -8.77 -59.84
XSWX:BDX
77GF Score
Becton Dickinson & Co XSWX:BDX
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-187 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of CHF-187 Mil mean?
Becton Dickinson (XSWX:BDX) has a Tax Provision of CHF-187 Mil as of Mar. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Tax Provision too high?
Becton Dickinson's current Tax Provision is CHF-187 Mil. Overall, Becton Dickinson has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Tax Provision compare to MDLN and RMD?
Becton Dickinson's Tax Provision of CHF-187 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Medical Devices & Instruments company?
A good Tax Provision depends on the Medical Devices & Instruments industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Tax Provision is CHF-187 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current Tax Provision of CHF-187 Mil. The stock's GF Value™ is CHF153.22, compared to a current price of CHF122.44 — trading 20.1% below its estimated fair value. The current Tax Provision is CHF-187 Mil. Becton Dickinson's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current Tax Provision is CHF-187 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF122.44 is trading 20.1% below its estimated GF Value™ of CHF153.22.

Key valuation signals for XSWX:BDX:

  • Tax Provision: CHF-187 Mil
  • GF Value™: CHF153.22 vs. price of CHF122.44 (20.1% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score

Get the complete analysis for XSWX:BDX

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF122.44
Price
CHF153.22
GF Value